Larken Laboratories, Inc.
11 drugs in NADAC|11 Generic,0 Brand
Larken Laboratories, Inc. lists 11 NDCs in the CMS NADAC file (11 generic, 0 brand), at an average NADAC of $0.21 per unit, with a week-over-week move of -2.1% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
11
11G / 0B
Avg Price / Unit
$0.2076
$0.05 – $0.77
Avg 7d Change
-2.15%
Across 7 drugs with changes
7d Activity
of 11 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
butalbital and acetaminophen market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Sigma-1 Agonist therapeutic class
Review the broader class where Larken Laboratories, Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Larken Laboratories, Inc. make?
Larken Laboratories, Inc. lists 11 NDCs in the CMS NADAC file — 11 generic and 0 brand products.
What is the average price of Larken Laboratories, Inc. drugs?
The average NADAC across Larken Laboratories, Inc.'s portfolio is $0.2076 per unit, ranging from $0.0512 to $0.7693.
What types of drugs does Larken Laboratories, Inc. make?
Larken Laboratories, Inc. makes drugs across 8 FDA pharmacologic classes. The most common by NDC count are Sigma-1 Agonist (3), Uncompetitive N-methyl-D-aspartate Receptor Antagonist (3), alpha-1 Adrenergic Agonist (3), Barbiturate (2), Tetracycline-class Drug (2).
Has Larken Laboratories, Inc. had any drug recalls?
No FDA enforcement recalls are matched to Larken Laboratories, Inc. in the openFDA feed.
How has Larken Laboratories, Inc.'s pricing changed recently?
Over the past 7 days, 1 Larken Laboratories, Inc. product rose and 6 fell, with a portfolio-wide average change of -2.1%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB butalbital and acetaminophen | $0.7692 per EA | — |
BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB butalbital and acetaminophen | $0.5709 per EA | -3.11% |
DEXAMETHASONE 1.5 MG TABLET Dexamethasone 1.5 mg | $0.1798 per EA | — |
OSCIMIN SL 0.125 MG TABLET Hyoscyamine Sulfate | $0.1707 per EA | -6.62% |
OSCIMIN 0.125 MG TABLET Hyoscyamine Sulfate | $0.1459 per EA | -3.72% |
DOXYCYCLINE HYCLATE 20 MG TAB Doxycycline Hyclate | $0.0984 per EA | +0.01% |
DOXYCYCLINE HYCLATE 20 MG TAB Doxycycline Hyclate | $0.0984 per EA | — |
LOHIST-DM SYRUP Brompheniramine Maleate, Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride | $0.0741 per ML | -0.63% |
NOHIST-DM LIQUID Chlorpheniramine Maleate, Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride | $0.0669 per ML | -0.56% |
LOHIST-D LIQUID Chlorpheniramine Maleate / Pseudoephedrine HCl | $0.0587 per ML | — |
ENDACOF-DM LIQUID Brompheniramine Maleate, Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride | $0.0512 per ML | -0.41% |